UPDATE : Tuesday, July 7, 2020
Kolon unveils trial results for Invossa at cartilage repair conference
Kolon Life Science said Friday that it has presented its local phase 3 clin...
by Lee Han-soo  |  2018-04-20 15:57
Blockbuster Remicade losing out to Korean biosimilars in US
Biosimilar drugs developed by Korean pharmaceutical firms are gradually car...
by So Jae-hyeon  |  2018-04-19 15:39
Hanmi gets FDA nod for nonalcoholic steatohepatitis treatment trials
Hanmi Pharmaceutical said Thursday that it has received approval to go ahea...
by Lee Han-soo  |  2018-04-19 15:29
Biotech stocks could be overpriced: analysts
Analysts are warning investors that biotech shares could be overpriced, as ...
by Nam Doo-hyun  |  2018-04-19 13:34
Pharmbio to market Shionogi’s dyspareunia treatment
Shionogi Inc. President and CEO John Keller (left) and Pharmbio Korea CEO N...
by Lee Han-soo  |  2018-04-18 14:10
ViroMed confirms VM202’s pain control in animal test
ViroMed said it has confirmed that VM202, an investigational gene therapy b...
by Nam Doo-hyun  |  2018-04-18 11:39
‘Genexine’s pipelines worth more than ₩3 trillion’
Biotech firm Genexine’s major pipelines could be worth more than 3 trillion...
by Nam Doo-hyun  |  2018-04-16 15:48
Daewoong opens biotech research lab in Indonesia
Daewoong Pharmaceutical said it has established a biotech research center a...
by So Jae-hyeon  |  2018-04-12 11:37
Biotech CEOs roll up sleeves for global biz
CEOs of Korea’s major biotech companies are directly involving in marketing...
by So Jae-hyeon  |  2018-04-10 12:09
Samsung Bioepis settles patent disputes with AbbVie on Humira
Samsung Bioepis said Thursday that it has settled a patent dispute with Abb...
by Lee Han-soo  |  2018-04-06 15:21
CTC Bio gets sales nod for erectile dysfunction treatment in Vietnam
CTC Bio said Tuesday that it has acquired marketing approval for its erecti...
by Lee Han-soo  |  2018-04-04 10:59
Steelmaker POSCO to challenge biotech sector
Korea’s largest steelmaker POSCO is entering the pharmaceutical market.Kwon...
by So Jae-hyeon  |  2018-04-03 11:58
Toolgen to develop hepatitis B treatment
Toolgen said Friday that it would develop a chronic hepatitis B treatment u...
by Lee Han-soo  |  2018-03-30 17:28
Kangstem Biotech wins patent on neural stem cells
Kangstem Biotech said Thursday that it has acquired a patent regarding the ...
by Lee Han-soo  |  2018-03-29 17:12
Huons wins sales approval for hyaluronic acid filler in Indonesia
Elravie Huons, a subsidiary of Huons Global, said Thursday that it has re...
by Lee Han-soo  |  2018-03-29 15:10
Stem cell therapy developers unaffected by Cha Biotech debacle
Shares of biotech firms specializing in stem cell therapies are performing ...
by Nam Doo-hyun  |  2018-03-26 15:58
KRX names CHA Biotech as administrative issue, leading to 30% stock fall
CHA Biotech, one of the promising bio-stocks, has been downgraded to an adm...
by Marian Chu, Lee Han-soo  |  2018-03-23 15:16
Foreigners buy SillaJen, Samsung BioLogics, dump Celltrion
Foreign investors net purchased shares of SillaJen and Samsung BioLogics, a...
by Nam Doo-hyun  |  2018-03-20 12:01
LG Chem gets approval for Enbrel biosimilar
LG Chem has received sales approval from the Ministry of Food and Drug Safe...
by Lee Han-soo  |  2018-03-19 12:14
Jointstem fails to win conditional nod
Jointstem, a stem cell therapy for degenerative arthritis, failed to obtain...
by Lee Hye-seon  |  2018-03-19 12:12
Back to Top